November 10, 2017 / 4:38 PM / a month ago

BRIEF-ARENA PHARMA SAYS COMPLETED FULL ENROLLMENT IN ETRASIMOD PHASE 2 STUDY IN ULCERATIVE COLITIS​

Nov 10 (Reuters) - Arena Pharmaceuticals Inc:

* ‍COMPLETED FULL ENROLLMENT IN ETRASIMOD PHASE 2 STUDY IN ULCERATIVE COLITIS​

* ‍LOOK FORWARD TO AVAILABILITY OF DATA FROM THE PHASE 2 TRIAL IN Q1 OF 2018 FOR ETRASIMOD​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below